Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C12H17N4O4PS |
| Molecular Weight | 344.327 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC1=C(CCOP(O)([O-])=O)SC=[N+]1CC2=CN=C(C)N=C2N
InChI
InChIKey=HZSAJDVWZRBGIF-UHFFFAOYSA-N
InChI=1S/C12H17N4O4PS/c1-8-11(3-4-20-21(17,18)19)22-7-16(8)6-10-5-14-9(2)15-12(10)13/h5,7H,3-4,6H2,1-2H3,(H3-,13,14,15,17,18,19)
| Molecular Formula | C12H17N4O4PS |
| Molecular Weight | 344.327 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Monophosphothiamine is thiamine derivative used for the treatment of neuritis, polyneuritis, asthenic conditions (weakness), as an additional remedy for chronic blood circulation insufficiency, chronic gastritis accompanied by motor and secretory disorders functions of the stomach. Monophosphothiamine underwent metabolic phosphorylation to active metabolite thiamine pyrophosphate, that acts as a coenzyme in the different metabolic process.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: https://www.rlsnet.ru/tn_index_id_5374.htm
0,01 - 0.03 g 3-4 times a day (after food) for 3-4 weeks.
Route of Administration:
Oral
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 22:39:31 GMT 2025
by
admin
on
Mon Mar 31 22:39:31 GMT 2025
|
| Record UNII |
71F2V60NN0
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
71F2V60NN0
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
PRIMARY | |||
|
3382778
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
PRIMARY | |||
|
DTXSID501114461
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
PRIMARY | |||
|
Thiamine monophosphate
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
PRIMARY | |||
|
10023-48-0
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
ALTERNATIVE | |||
|
DB03416
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
PRIMARY | |||
|
495-23-8
Created by
admin on Mon Mar 31 22:39:31 GMT 2025 , Edited by admin on Mon Mar 31 22:39:31 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
|